Previous 10 | Next 10 |
2023-10-19 07:37:22 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about. Moving stocks this morning are a regulator update, share offering news...
2023-09-25 08:11:42 ET More on Jasper Therapeutics Seeking Alpha’s Quant Rating on Jasper Therapeutics Historical earnings data for Jasper Therapeutics Financial information for Jasper Therapeutics For further details see: Jasper Therapeutics appoi...
2023-09-21 08:19:38 ET More on Atreca Seeking Alpha’s Quant Rating on Atreca Historical earnings data for Atreca Financial information for Atreca Atreca terminates lease agreement, CFO Cross steps down Atreca receives Nasdaq notice on non-compl...
SAN CARLOS, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced th...
2023-09-14 16:19:15 ET More on Atreca Seeking Alpha’s Quant Rating on Atreca Historical earnings data for Atreca Financial information for Atreca Atreca Approaches A Major Go/No-Go Decision For further details see: Atreca receives Nasdaq no...
2023-08-10 17:48:24 ET Atreca press release ( NASDAQ: BCEL ): Q2 GAAP EPS of -$0.49 beats by $0.08 . As of June 30, 2023, cash and cash equivalents and investments totaled $38.5 million. For further details see: Atreca GAAP EPS of -$0.49 beats by $0.08
Suspending development of ATRC-101 Cost-saving measures include 40% workforce reduction Focusing on advancing earlier stage ADC candidates and preserving discovery capabilities SAN CARLOS, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a cl...
2023-07-13 13:03:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tech companies in certain high-growth sectors like semiconductors, AI, and cloud predominantly drove this year’s bull market. But while these giants made headlines, many penny stocks...
2023-06-21 10:07:44 ET Gainers: Ocean Biomedical ( OCEA ) +43% . PetVivo Holdings ( PETV ) +23% . Patterson Companies ( PDCO ) +14% . Zentalis Pharmaceuticals ( ZNTL ) +5% . RenovoRx ( RNXT ) +4% . Losers: uniQure ( ...
2023-06-20 19:22:03 ET Summary BCEL has improved enrollment rates in its phase 1b ATRC-101 study, with 81 patients enrolled as of May 10, 2023. The company has enough cash to reach the readout from another round of data in the ATRC-101 trial, but may only have a couple of quarters...
News, Short Squeeze, Breakout and More Instantly...
Atreca Inc. Company Name:
BCEL Stock Symbol:
NYSE Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomi...